Tags: SOCMA Member News
The CJB companies (CJB Industries, Inc. and CJB Applied Technologies, LLC) have announced a cooperative venture with National FFA to benefit the companies who support National FFA as well as the National FFA itself.
September 30, 2020
With a tremendous emphasis on the safety of its employees and community, Manufacturers Chemicals, LLC is pleased to announce it has reached two million man hours without a lost-time incident as classified by the Occupational Safety and Health Administration (OSHA).
September 28, 2020
It is with great sadness that we share the passing of Michael L. Shamie, Founder, CEO and President of Avatar Corporation, who died in the early morning on Monday, August 24.
September 17, 2020
Humanigen, a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper response called ‘cytokine storm,’ and Lonza today announced a strategic collaboration to expand the manufacturing capacity for lenzilumab, currently in Phase 3 clinical trials for COVID-19, in advance of potential Emergency Use Authorization in 2020 and subsequent commercialization.
September 16, 2020
Lonza and Sheba Medical Center announced the first patient has been treated at Sheba Medical Center with a CD19 CAR-T cell immunotherapy manufactured using Lonza’s Cocoon® Platform.
September 8, 2020
President Trump visited Volunteer Pastilles, LLC Lake Charles plant on Saturday, August 29, while he was in Lake Charles assessing the damage from Hurricane Laura.
September 2, 2020
Sun Chemical released its Summer 2020 Regulatory Newsletter for customers which is now available.
August 31, 2020
Sun Chemical has organized a Corporate Sustainability Committee to further strengthen its approach to addressing the sustainability needs of the packaging industry.
August 17, 2020
Solvay signed a global distribution agreement with Strem Chemicals, Inc., a manufacturer of high-purity specialty products, to fulfill commercial sampling and research requests for its specialty phosphorus products.
August 12, 2020
Kodiak Sciences, a clinical-stage biopharmaceutical company specializing in novel ophthalmic therapies, and Lonza announced today that the companies have signed a long-term contract for manufacturing KSI-301, an Antibody Biopolymer Conjugate (ABC) that is a potential first-line treatment for retinal vascular diseases.
August 10, 2020
